[{"address1": "100 Overlook Center", "address2": "Suite 102", "city": "Princeton", "state": "NJ", "zip": "08540", "country": "United States", "phone": "609 375 2227", "website": "https://www.sonnetbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Sonnet BioTherapeutics Holdings, Inc., a biotechnology company, owns a platform for biologic medicines of single or bifunctional action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead product candidate is SON-1010, a fully human single-chain version of interleukin 12 for the treatment of solid tumor indications, including ovarian cancer, non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 to treat chemotherapy-induced peripheral neuropathy (CIPN), and diabetic peripheral neuropathy; SON-1210, a bispecific compound for solid tumor indications, including colorectal cancer; SON-1411, a bifunctional combination of human interleukin 18 (IL-18) inhibitor binding protein and single-chain human IL-12 (IL-12) for solid tumor cancers; and SON-1400, a monofunctional fusion protein comprising the IL-18 binding protein resistant domain linked to the FHAB. It has a license agreement with New Life Therapeutics Pte, Ltd. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin-6; and strategic development collaboration with Sarcoma Oncology Center to advance SON-1210. The company is headquartered in Princeton, New Jersey.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Mr. Raghu  Rao", "age": 61, "title": "Interim CEO & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 116500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. John K. Cini Ph.D.", "age": 71, "title": "Chief Scientific Officer & Co-Founder", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 397750, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Donald J. Griffith CPA, CPA", "age": 75, "title": "CFO, Financial Controller & Director", "yearBorn": 1949, "fiscalYear": 2024, "totalPay": 90256, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen J. McAndrew Ph.D.", "age": 70, "title": "President & Chief Business Officer", "yearBorn": 1954, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gael  Hedou Ph.D.", "age": 52, "title": "Chief Operating Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Susan  Dexter", "age": 69, "title": "Chief Technical Officer", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Richard T. Kenney FACP, M.D.", "age": 66, "title": "Chief Medical Officer", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Manuel  Dafonseca", "title": "Head of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.16, "open": 1.16, "dayLow": 1.16, "dayHigh": 1.19, "regularMarketPreviousClose": 1.16, "regularMarketOpen": 1.16, "regularMarketDayLow": 1.16, "regularMarketDayHigh": 1.19, "payoutRatio": 0.0, "forwardPE": -0.07820855, "volume": 21118, "regularMarketVolume": 21118, "averageVolume": 40993, "averageVolume10days": 45680, "averageDailyVolume10Day": 45680, "bid": 0.8496, "ask": 1.49, "bidSize": 2, "askSize": 2, "marketCap": 3703997, "fiftyTwoWeekLow": 1.08, "fiftyTwoWeekHigh": 16.0, "priceToSalesTrailing12Months": 3.703997, "fiftyDayAverage": 1.2958, "twoHundredDayAverage": 2.9453, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1685573, "profitMargins": 0.0, "floatShares": 3090102, "sharesOutstanding": 3165810, "sharesShort": 98090, "sharesShortPriorMonth": 164411, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.031, "heldPercentInsiders": 0.015319999, "heldPercentInstitutions": 0.05242, "shortRatio": 2.91, "shortPercentOfFloat": 0.0312, "impliedSharesOutstanding": 3165810, "bookValue": 0.212, "priceToBook": 5.518868, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -13285976, "trailingEps": -12.07, "forwardEps": -14.96, "lastSplitFactor": "1:8", "lastSplitDate": 1727654400, "enterpriseToRevenue": 1.686, "enterpriseToEbitda": -0.122, "52WeekChange": -0.91027606, "SandP52WeekChange": 0.1189177, "quoteType": "EQUITY", "currentPrice": 1.17, "targetHighPrice": 20.0, "targetLowPrice": 20.0, "targetMeanPrice": 20.0, "targetMedianPrice": 20.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 2059284, "totalCashPerShare": 0.659, "ebitda": -13768739, "totalDebt": 90446, "quickRatio": 0.894, "currentRatio": 1.026, "totalRevenue": 1000000, "debtToEquity": 13.657, "revenuePerShare": 0.534, "returnOnAssets": -1.7675301, "returnOnEquity": -7.14965, "grossProfits": -69009, "freeCashflow": -7733483, "operatingCashflow": -11621285, "grossMargins": -0.06901, "ebitdaMargins": 0.0, "operatingMargins": -13.78088, "financialCurrency": "USD", "symbol": "SONN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Sonnet BioTherapeutics Holdings", "longName": "Sonnet BioTherapeutics Holdings, Inc.", "marketState": "CLOSED", "epsTrailingTwelveMonths": -12.07, "epsForward": -14.96, "epsCurrentYear": -3.46, "priceEpsCurrentYear": -0.33815026, "fiftyDayAverageChange": -0.12580001, "fiftyDayAverageChangePercent": -0.0970829, "twoHundredDayAverageChange": -1.7753001, "twoHundredDayAverageChangePercent": -0.602757, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1162305000000, "corporateActions": [], "postMarketTime": 1748638221, "regularMarketTime": 1748635200, "exchange": "NCM", "messageBoardId": "finmb_410378138", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.8620681, "regularMarketPrice": 1.17, "postMarketChangePercent": 0.0, "postMarketPrice": 1.17, "postMarketChange": 0.0, "regularMarketChange": 0.00999999, "regularMarketDayRange": "1.16 - 1.19", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 40993, "fiftyTwoWeekLowChange": 0.089999914, "fiftyTwoWeekLowChangePercent": 0.083333254, "fiftyTwoWeekRange": "1.08 - 16.0", "fiftyTwoWeekHighChange": -14.83, "fiftyTwoWeekHighChangePercent": -0.926875, "fiftyTwoWeekChangePercent": -91.0276, "dividendDate": 1585785600, "earningsTimestamp": 1747166400, "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755520200, "isEarningsDateEstimate": true, "displayName": "Sonnet BioTherapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-31"}]